American Century Companies Inc Cytek Biosciences, Inc. Transaction History
American Century Companies Inc
- $168 Billion
- Q4 2024
A detailed history of American Century Companies Inc transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 204,745 shares of CTKB stock, worth $859,929. This represents 0.0% of its overall portfolio holdings.
Number of Shares
204,745
Previous 184,943
10.71%
Holding current value
$859,929
Previous $1.02 Million
29.69%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CTKB
# of Institutions
151Shares Held
74MCall Options Held
1KPut Options Held
0-
Black Rock Inc. New York, NY17.1MShares$71.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$49.2 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD8.25MShares$34.6 Million1.27% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$28 Million1.65% of portfolio
-
State Street Corp Boston, MA4.51MShares$18.9 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $565M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...